CRISPR Therapeutics (CRSP) News Today → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free CRSP Stock Alerts $52.43 -0.86 (-1.61%) (As of 12:21 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCRISPR Therapeutics (NASDAQ:CRSP) PT Lowered to $65.00 at Wells Fargo & Companymarketbeat.com - May 9 at 12:27 PMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 1.7% on Disappointing Earningsmarketbeat.com - May 9 at 12:09 PMCRISPR Therapeutics' (CRSP) "Neutral" Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - May 9 at 11:47 AMStrong Buy Rating for Crispr Therapeutics AG Amid Innovative Advances and Global Expansionmarkets.businessinsider.com - May 9 at 9:01 AMCRISPR Therapeutics (NASDAQ:CRSP) Given New $52.00 Price Target at Robert W. Bairdmarketbeat.com - May 9 at 8:44 AMCRISPR Therapeutics to Present at the Bank of America Securities Health Care Conferenceglobenewswire.com - May 9 at 8:30 AMCRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 8 at 11:03 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 3.1%marketbeat.com - May 8 at 5:29 PMCRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Resultsglobenewswire.com - May 8 at 4:00 PMBuy Rating on CRSP: Promising Early Adoption and Expansion Signal Growthmarkets.businessinsider.com - May 8 at 9:05 AMCRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approachglobenewswire.com - May 8 at 7:00 AMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 1.4% marketbeat.com - May 7 at 3:52 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 0%marketbeat.com - May 6 at 7:33 PMbluebird reports first commercial cell collection for Lyfgeniamsn.com - May 6 at 1:23 PMVestmark Advisory Solutions Inc. Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - May 5 at 6:25 PMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 2.3%americanbankingnews.com - May 5 at 4:54 AM3 Biotech Stocks With the Potential to Make You an Overnight Millionaireinvestorplace.com - May 4 at 12:00 PMCrispr Therapeutics: Market Misunderstanding Is Your Buying Opportunity (Upgrade)seekingalpha.com - May 3 at 4:59 PMShhh! 3 Secret Gene Editing Stocks Flying Below Wall Street's Radarinvestorplace.com - May 3 at 2:18 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 1.2%marketbeat.com - May 2 at 2:47 PMBuy Rating on Crispr Therapeutics: Anticipated Clinical Catalysts and Undervalued Autoimmune Prospectsmarkets.businessinsider.com - May 2 at 9:20 AMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.1% marketbeat.com - May 1 at 1:59 PMStock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plungeinvestorplace.com - May 1 at 11:59 AMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 1.5%marketbeat.com - April 30 at 3:38 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 2.1%marketbeat.com - April 29 at 3:17 PMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 5%marketbeat.com - April 25 at 6:18 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading 0.5% Higher marketbeat.com - April 24 at 4:22 PMCrispr Therapeutics: Now Is The Time To Buyseekingalpha.com - April 24 at 12:40 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 4.5%marketbeat.com - April 23 at 2:58 PMCRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meetingglobenewswire.com - April 22 at 4:30 PMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.2%marketbeat.com - April 22 at 1:55 PMCRISPR Therapeutics AG (NASDAQ:CRSP) Holdings Cut by Allspring Global Investments Holdings LLCmarketbeat.com - April 22 at 4:41 AMCRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intactmarkets.businessinsider.com - April 20 at 12:06 AMCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 0.8% on Analyst Upgrademarketbeat.com - April 19 at 11:37 AMSamarth Kulkarni Sells 19,582 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stockinsidertrades.com - April 19 at 5:06 AMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 2.8% After Analyst Upgrademarketbeat.com - April 18 at 2:47 PMCitigroup Boosts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $89.00marketbeat.com - April 18 at 1:28 PMCRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 19,582 Sharesmarketbeat.com - April 17 at 6:38 PMCRISPR Therapeutics's Options Frenzy: What You Need to Knowbenzinga.com - April 17 at 6:25 PMBullish Trendline Has Never Failed Crispr Therapeutics Stockfinance.yahoo.com - April 17 at 1:25 PMIs Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?finance.yahoo.com - April 17 at 1:25 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 1.8%marketbeat.com - April 17 at 12:42 PMCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 1.1%marketbeat.com - April 16 at 2:35 PMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 1.5% marketbeat.com - April 15 at 3:37 PMCarnegie Capital Asset Management LLC Sells 15,180 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - April 15 at 9:24 AMCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Capital Advisors Inc. OKmarketbeat.com - April 13 at 4:52 PM3 Magnificent Stocks That Could Double or More by 2030fool.com - April 13 at 8:47 AMAsset Management One Co. Ltd. Invests $1.74 Million in CRISPR Therapeutics AG (NASDAQ:CRSP)marketbeat.com - April 13 at 5:10 AMCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1%marketbeat.com - April 12 at 2:02 PMCRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.2% marketbeat.com - April 11 at 2:28 PM Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Proof that the Musk/Bezos rivalry is about to hit a new level (Ad)Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats… Go here now for full story. CRSP Media Mentions By Week CRSP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.110.36▲Average Medical News Sentiment CRSP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼219▲CRSP Articles Average Week Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Krystal Biotech News Halozyme Therapeutics News Immunovant News ImmunityBio News SpringWorks Therapeutics News Iovance Biotherapeutics News Immunocore News CG Oncology News Arcellx News Revolution Medicines News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
